drugset / Trial / NCT07276568
Safety, Tolerability, and Preliminary Efficacy of Hepatocyte-like Cell Injection for the Prevention and Treatment of Small-for-Size Syndrome
Non-randomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the safety, tolerability, and preliminary efficacy of rectus sheath injection of hepatocyte-like cells in the treatment and prevention of small-for-size syndrome, with the ultimate goal of improving patient survival.
Timeline
- Start
- 2025-12-17
- Primary completion
- 2028-12-01
- Completion
- 2029-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CiPS-derived hepatocyte cells | Unknown | 6e+07 cells/kg | Intramuscular |
| Subject | CiPS-derived hepatocyte cells | Unknown | 1.2e+08 cells/kg | Intramuscular |
Indications
No indication recorded.